Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Is Rapid Molecular Testing enough In Screening Resistant Tuberculosis In Community

Dhaker Ashok, Bahal Ashish, View ORCID ProfileMangal Vishal, K Yadav Arun, Singhal Anuj, Gupta Anoushka
doi: https://doi.org/10.1101/2021.02.25.21252270
Dhaker Ashok
1Department of Internal Medicine, Armed Forces Medical College, Pune, Maharashtra, India, 4110040
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bahal Ashish
2Department of Microbiology, Army Hospital Research & Referral, New Delhi, India-110010
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mangal Vishal
3Department of Internal Medicine, Armed Forces Medical College, Pune, Maharashtra India, 4110040
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mangal Vishal
K Yadav Arun
4Department of Community Medicine, Armed Forces Medical College, Pune, Maharashtra, India, 4110040
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Singhal Anuj
5Department of Internal Medicine, Army Hospital Research & Referral, New Delhi, India-110010
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: purnimanuj@gmail.com
Gupta Anoushka
6Undergraduate Wing, Armed Forces Medical College, Pune, Maharashtra, India, 4110040
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The study aimed to compare the sensitivity and specificity of cartridge based nucleic acid amplification test (CBNAAT) for diagnosis of Drug-Resistant tuberculosis (DRTB) with culture sensitivity assays.

Methods Patients with cough symptoms for more than two weeks with any one symptom such as night sweats, fever, and unintentional weight loss were enrolled. Cases where Mycobacterium Tuberculosis was detected on sputum CBNAAT, were included in the study. Demographic variables, clinical features, and chest radiographs were collected. Each sputum sample was divided into three aliquots: smear microscopy, culture, and genotypic drug sensitivity testing (DST). Results of all three diagnostic modalities were compared with CBNAAT.

Results Out of 236 patients with sputum positive CBNAAT, 49.4 % (117/236) were rifampicin-resistant while 50. 6 % (119/236) were Rifampicin sensitive. The genotypic DST assays carried out on all enrolled patients showed that 76. 3 % (181/236) patients were resistant to one or more first-line or second-line antitubercular (ATT) drugs, while 23.7 % (55/236) patients were sensitive to all ATT drugs. On concordant analysis of CB NAAT with DST assays, we found that among 119 CB NAAT rifampicin sensitive patients, 66 patients were resistant to first-line or second-line antitubercular drugs.

Conclusion This study found that the screening of DRTB with CBNAAT at the community level is suboptimal compared to the gold standard. Although CBNAAT’s sensitivity in detecting DRTB is significantly higher, the specificity is lower in that population who have received ATT earlier.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Ethical Committee at Armed Forces Medical College discussed the project and approved it vide letter number IEC/ Oct/2018 dated 22 Oct 2018

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All the data is available with the authors on request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 01, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Is Rapid Molecular Testing enough In Screening Resistant Tuberculosis In Community
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Is Rapid Molecular Testing enough In Screening Resistant Tuberculosis In Community
Dhaker Ashok, Bahal Ashish, Mangal Vishal, K Yadav Arun, Singhal Anuj, Gupta Anoushka
medRxiv 2021.02.25.21252270; doi: https://doi.org/10.1101/2021.02.25.21252270
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Is Rapid Molecular Testing enough In Screening Resistant Tuberculosis In Community
Dhaker Ashok, Bahal Ashish, Mangal Vishal, K Yadav Arun, Singhal Anuj, Gupta Anoushka
medRxiv 2021.02.25.21252270; doi: https://doi.org/10.1101/2021.02.25.21252270

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (496)
  • Anesthesia (106)
  • Cardiovascular Medicine (1110)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (275)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (505)
  • Epidemiology (9796)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2327)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1567)
  • Health Policy (737)
  • Health Systems and Quality Improvement (608)
  • Hematology (238)
  • HIV/AIDS (508)
  • Infectious Diseases (except HIV/AIDS) (11669)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2154)
  • Nursing (134)
  • Nutrition (340)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (519)
  • Oncology (1185)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (221)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (314)
  • Pediatrics (699)
  • Pharmacology and Therapeutics (303)
  • Primary Care Research (268)
  • Psychiatry and Clinical Psychology (2195)
  • Public and Global Health (4685)
  • Radiology and Imaging (786)
  • Rehabilitation Medicine and Physical Therapy (458)
  • Respiratory Medicine (625)
  • Rheumatology (276)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (212)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)